Dianthus Therapeutics (DNTH) Misses Q4 EPS by 143c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 EPS of ($1.43). Revenue for the quarter came in at $280 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Urban Outfitters (URBN) Misses Q2 EPS by 1c
• BMO Capital on U.S. boat registrations: macroeconomic conditions continue to pressure retail demand